MedPath

SUPplementary REgional anesthesia in MAmma surgery (SUPREMA trial).

Recruiting
Conditions
Mamma surgeryBreast cancerBorst operatieBorstkanker
Registration Number
NL-OMON22294
Lead Sponsor
.P.TanApotheek Reinier de Graaf Groep DelftPostbus 50112600 GA Delftvtan@rdgg.nlNo sponsors
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

1. Women;

2. One-sided breast conserving surgery with or without sentinel node biopsy;

Exclusion Criteria

1. Known allergy to amide type local anesthetics;

2. Severe liver failure;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative vomiting in the first 24 hours.
Secondary Outcome Measures
NameTimeMethod
1. Postoperative nausea at entrance at entry in the recovery room and 4,8 and 24 hours after surgery (VAS score 0-10 cm);<br /> <br>2. Postoperative pain at entrance at entry in the recovery room and 4,8 and 24 hours after surgery (VAS score 0-10 cm);<br /> <br>3. Need for postoperative opiates (frequency and total dose in first 24 hours);<br /><br>4. Need for postoperative anti-emetics (frequency and total dose in first 24 hours).<br>
© Copyright 2025. All Rights Reserved by MedPath